Analyst firms · Morgan Stanley · CI
Morgan Stanley CI price target and rating history
The Cigna Group (CI) · Health Care
Morgan Stanley rates The Cigna Group (CI) Overweight with a $347 price target, as of its latest action on Nov 23, 2022. It has published 7 rating actions on CI since August 2021, including 1 upgrade and 2 downgrades. Across 6 firms with a CI price target in the last 12 months, the median target is $305.50.
- Current rating
- Overweight
- Price target
- $347
- Median target, all firms
- $305.50
- Actions on CI
- 7
Morgan Stanley price target on CI
Every Morgan Stanley rating on CI
- Nov 23, 2022
- Jun 22, 2022
- Feb 10, 2022
- Dec 17, 2021
- Dec 16, 2021
- Nov 12, 2021
- Aug 31, 2021
How other firms rate CI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Evercore ISI | In-line | $290 | Sep 9, 2026 |
| Jefferies | Hold | $307 | Aug 4, 2026 |
| Raymond James | Outperform | $320 | Aug 3, 2026 |
| Barclays | Equal Weight | $304 | May 26, 2026 |
| Deutsche Bank | Hold | $302 | May 20, 2026 |
| Bernstein | Outperform | $358 | Mar 12, 2026 |
Questions about Morgan Stanley and CI
- What is Morgan Stanley's price target for CI?
- Morgan Stanley's latest stated price target for The Cigna Group (CI) is $347, from its action on Nov 23, 2022.
- What is Morgan Stanley's rating on CI?
- Morgan Stanley rates CI Overweight, a bullish rating, as of Nov 23, 2022.
- When did Morgan Stanley last change its view on CI?
- On Nov 23, 2022, Morgan Stanley resumes coverage at Overweight, price target $318 to $347.
- How does Morgan Stanley's CI target compare with other analysts?
- Across 6 firms with a CI price target in the last 12 months, the median target is $305.50.
More CI rating histories
All Morgan Stanley ratingsCI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.